These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


337 related items for PubMed ID: 8874661

  • 21. Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models.
    Spangler DL, Abelson MB, Ober A, Gotnes PJ.
    Clin Ther; 2003 Aug; 25(8):2245-67. PubMed ID: 14512132
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Mometasone furoate nasal spray for moderate-to-severe nasal congestion in subjects with seasonal allergic rhinitis.
    Meltzer EO, Shekar T, Teper AA.
    Allergy Asthma Proc; 2011 Aug; 32(2):159-67. PubMed ID: 21439168
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Effectiveness of mometasone furoate nasal spray in seasonal allergic rhinitis. First experiences in practice after the introduction of the drug in Hungary].
    Farkas H, Pintér J, Kalabay L, Jakab L, Visy B, Fekete B.
    Orv Hetil; 2002 Aug 18; 143(33):1929-33. PubMed ID: 12244656
    [Abstract] [Full Text] [Related]

  • 27. Onset and duration of action of nasal sprays in seasonal allergic rhinitis patients: olopatadine hydrochloride versus mometasone furoate monohydrate.
    Patel D, Garadi R, Brubaker M, Conroy JP, Kaji Y, Crenshaw K, Whitling A, Wall GM.
    Allergy Asthma Proc; 2007 Aug 18; 28(5):592-9. PubMed ID: 18034980
    [Abstract] [Full Text] [Related]

  • 28. Once-daily mometasone furoate nasal spray: efficacy and safety of a new intranasal glucocorticoid for allergic rhinitis.
    Davies RJ, Nelson HS.
    Clin Ther; 1997 Aug 18; 19(1):27-38; discussion 2-3. PubMed ID: 9083706
    [Abstract] [Full Text] [Related]

  • 29. Lack of hypothalamic-pituitary-adrenal axis suppression with once-daily or twice-daily beclomethasone dipropionate aqueous nasal spray administered to patients with allergic rhinitis.
    Brannan MD, Herron JM, Reidenberg P, Affrime MB.
    Clin Ther; 1995 Aug 18; 17(4):637-47. PubMed ID: 8565027
    [Abstract] [Full Text] [Related]

  • 30. Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis.
    Minshall E, Ghaffar O, Cameron L, O'Brien F, Quinn H, Rowe-Jones J, Davies RJ, Prior A, Lund VJ, Mackay IS, Nolop K, Lutsky B, Durham SR, Hamid Q.
    Otolaryngol Head Neck Surg; 1998 May 18; 118(5):648-54. PubMed ID: 9591864
    [Abstract] [Full Text] [Related]

  • 31. Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: results of recent clinical trials.
    Dibildox J.
    J Allergy Clin Immunol; 2001 Jul 18; 108(1 Suppl):S54-8. PubMed ID: 11449207
    [Abstract] [Full Text] [Related]

  • 32. Once daily fluticasone propionate is as effective for perennial allergic rhinitis as twice daily beclomethasone diproprionate.
    van As A, Bronsky EA, Dockhorn RJ, Grossman J, Lumry W, Meltzer EO, Seltzer JM, Rogenes PR.
    J Allergy Clin Immunol; 1993 Jun 18; 91(6):1146-54. PubMed ID: 8509578
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Fluticasone propionate given once daily is as effective for seasonal allergic rhinitis as beclomethasone dipropionate given twice daily.
    Ratner PH, Paull BR, Findlay SR, Hampel F, Martin B, Kral KM, Rogenes PR.
    J Allergy Clin Immunol; 1992 Sep 18; 90(3 Pt 1):285-91. PubMed ID: 1527313
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Comparative safety and efficacy of two formulations of mometasone nasal spray in adult seasonal allergic rhinitis.
    Kuna P, Wasiak W, Jones S, Kreft KZ.
    Allergy Asthma Proc; 2014 Sep 18; 35(4):332-7. PubMed ID: 24871808
    [Abstract] [Full Text] [Related]

  • 38. Short-term lower leg growth rate in children with rhinitis treated with intranasal mometasone furoate and budesonide.
    Agertoft L, Pedersen S.
    J Allergy Clin Immunol; 1999 Nov 18; 104(5):948-52. PubMed ID: 10550737
    [Abstract] [Full Text] [Related]

  • 39. A randomized controlled trial of mometasone furoate nasal spray for the treatment of nasal polyposis.
    Stjärne P, Mösges R, Jorissen M, Passàli D, Bellussi L, Staudinger H, Danzig M.
    Arch Otolaryngol Head Neck Surg; 2006 Feb 18; 132(2):179-85. PubMed ID: 16490876
    [Abstract] [Full Text] [Related]

  • 40. Comparison of efficacy of mometasone furoate versus clarithromycin in the treatment of chronic rhinosinusitis without nasal polyps in Chinese adults.
    Zeng M, Long XB, Cui YH, Liu Z.
    Am J Rhinol Allergy; 2011 Feb 18; 25(6):e203-7. PubMed ID: 22185725
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.